Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma
Clinical trial NCT00477412 · COMPLETED
Trial details
- NCT number
- NCT00477412
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-03
- Primary completion
- 2020-10-28
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.